Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaokui Mo

Showing results (161-170 of 207) with videos related to

Pageof 21
Sort By:
Blood|October 18, 2011
AP-1 elements and TCL1 protein regulate expression of the gene encoding protein tyrosine phosphatase PTPROt in leukemiaTasneem Motiwala, Nicola Zanesi, Jharna Datta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2016
Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1-Mediated LipogenesisFeng Geng, Xiang Cheng, Xiaoning Wu, et al.
Oncotarget|September 25, 2023
Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomideAlessandro Canella, Hector Cordero Nieves, Douglas W Sborov, et al.
Blood|December 8, 2009
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibodyFarrukh T Awan, Rosa Lapalombella, Rossana Trotta, et al.
Plos One|March 12, 2015
A novel miRNA-based predictive model for biochemical failure following post-prostatectomy salvage radiation therapyErica Hlavin Bell, Simon Kirste, Jessica L Fleming, et al.
Plos One|July 28, 2017
Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcomaPeter Y Yu, Heather L Gardner, Ryan Roberts, et al.
Pathogens & Immunity|November 4, 2017
Prospective Analysis of Lipid Composition Changes with Antiretroviral Therapy and Immune Activation in Persons Living with HIVMartha A Belury, Emily Bowman, Janelle Gabriel, et al.
Oncotarget|October 3, 2015
HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomideAlessandro Canella, Hector Cordero Nieves, Douglas W Sborov, et al.
The Journal of Biological Chemistry|October 27, 2016
Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia CellsKavin Fatehchand, Elizabeth L McMichael, Brenda F Reader, et al.
Cell Reports. Medicine|September 5, 2024
Combinatorial targeting of glutamine metabolism and lysosomal-based lipid metabolism effectively suppresses glioblastomaYaogang Zhong, Feng Geng, Logan Mazik, et al.
Pageof 21

Showing results (161-170 of 207) with videos related to

Sort By:
Pageof 21
Blood|October 18, 2011
AP-1 elements and TCL1 protein regulate expression of the gene encoding protein tyrosine phosphatase PTPROt in leukemiaTasneem Motiwala, Nicola Zanesi, Jharna Datta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2016
Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1-Mediated LipogenesisFeng Geng, Xiang Cheng, Xiaoning Wu, et al.
Oncotarget|September 25, 2023
Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomideAlessandro Canella, Hector Cordero Nieves, Douglas W Sborov, et al.
Blood|December 8, 2009
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibodyFarrukh T Awan, Rosa Lapalombella, Rossana Trotta, et al.
Plos One|March 12, 2015
A novel miRNA-based predictive model for biochemical failure following post-prostatectomy salvage radiation therapyErica Hlavin Bell, Simon Kirste, Jessica L Fleming, et al.
Plos One|July 28, 2017
Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcomaPeter Y Yu, Heather L Gardner, Ryan Roberts, et al.
Pathogens & Immunity|November 4, 2017
Prospective Analysis of Lipid Composition Changes with Antiretroviral Therapy and Immune Activation in Persons Living with HIVMartha A Belury, Emily Bowman, Janelle Gabriel, et al.
Oncotarget|October 3, 2015
HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomideAlessandro Canella, Hector Cordero Nieves, Douglas W Sborov, et al.
The Journal of Biological Chemistry|October 27, 2016
Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia CellsKavin Fatehchand, Elizabeth L McMichael, Brenda F Reader, et al.
Cell Reports. Medicine|September 5, 2024
Combinatorial targeting of glutamine metabolism and lysosomal-based lipid metabolism effectively suppresses glioblastomaYaogang Zhong, Feng Geng, Logan Mazik, et al.
Pageof 21